First filing for 2012

Cancer Genetics Inc. became the first life sciences company to file for an IPO in the New Year. The diagnostics company, which is seeking to raise up to $50 million, develops DNA probes using fluorescent in situ hybridization (FISH) and microarrays using comparative genomic hybridization.

Cancer Genetics has a CLIA-certified laboratory to perform its MatBA-CLL test, which identifies genomic markers associated with chronic lymphocytic leukemia (CLL) to help physicians diagnose the disease as well as determine treatment and prognosis...